Incidence of carbapenem-resistant Pseudomonas aeruginosa in diabetes and cancer patients.
Indian J Med Microbiol
;
2008 Jul-Sep; 26(3): 238-40
Article
Dans Anglais
| IMSEAR
| ID: sea-53659
ABSTRACT
Two hundred and thirty isolates of Pseudomonas aeruginosa were obtained from samples of patients having diabetes (75%), cancer (20%), and both diabetes and cancer (5%) who were admitted to a tertiary care hospital in Western India from January to December 2006. These isolates were tested for susceptibility to antipseudomonal drugs and considered to be resistant to carbapenem when the zone of inhibition around imipenem and meropenem discs was < or =13 mm. Of these 230 isolates, 26% were found to be carbapenem resistant. The rapid dissemination of carbapenem resistance is worrisome and calls for the implementation of surveillance studies as well as judicious use of antibiotics.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Pseudomonas aeruginosa
/
Infections à Pseudomonas
/
Humains
/
Tests de sensibilité microbienne
/
Carbapénèmes
/
Résistance aux bêta-lactamines
/
Complications du diabète
/
Hospitalisation
/
Inde
/
Tumeurs
Type d'étude:
Etude d'incidence
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Indian J Med Microbiol
Thème du journal:
Microbiology
Année:
2008
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS